Amarin Corp Plc (AMRN)

[ziploc_1]

C.B...."It’s been estimated that the total Chinese patient population in the REDUCE-IT label is 330,000,000 (about the entire US population)"

This boggles the imagination...If only 1% of the potential Chinese patient population who could benefit by being on Vascepa(a benefit, which was proven by the R-IT study), could be prescribed Vascepa...the entire global fishing industry, as we know it, would soon be unable to supply enough EPA for world market consumption...and instead, we would have resort to algae farms for further supply of EPA.